A Brief Review on the Pathological Role of Decreased Blood Flow Affected in Retinitis Pigmentosa
- PMID: 29682340
- PMCID: PMC5845519
- DOI: 10.1155/2018/3249064
A Brief Review on the Pathological Role of Decreased Blood Flow Affected in Retinitis Pigmentosa
Abstract
Retinitis pigmentosa (RP) represents a clinically and genetically heterogeneous disease characterized by progressive photoreceptor loss. In recent years, research has been rarely made in blood flow affected in RP. The specific mechanism of blood flow affected in RP is not completely clear. A number of studies indicated that the decreased blood flow was related to RP. According to clinical observation and treatment experience, Chinese medicine considered that blood stasis runs throughout the RP disease progression, and the blood stasis corresponding to Chinese herbal medicine has a positive effect on the clinical treatment of RP. Therefore, we proposed that the decreased blood flow may participate in the lesion. In this article, we will review the findings on the decreased blood flow affected in RP from the perspective of modern medicine and Chinese medicine.
Figures

Similar articles
-
[Research progress of treatment strategies for retinitis pigmentosa].Zhonghua Yan Ke Za Zhi. 2017 Feb 11;53(2):148-153. doi: 10.3760/cma.j.issn.0412-4081.2017.02.015. Zhonghua Yan Ke Za Zhi. 2017. PMID: 28260368 Review. Chinese.
-
[Early therapeutic trials for retinitis pigmentosa].Bull Acad Natl Med. 2003;187(9):1685-92; discussion 1692-4. Bull Acad Natl Med. 2003. PMID: 15369238 Review. French.
-
Non-syndromic retinitis pigmentosa.Prog Retin Eye Res. 2018 Sep;66:157-186. doi: 10.1016/j.preteyeres.2018.03.005. Epub 2018 Mar 27. Prog Retin Eye Res. 2018. PMID: 29597005 Review.
-
Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient.Oncotarget. 2017 Oct 10;8(51):88345-88350. doi: 10.18632/oncotarget.21728. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179439 Free PMC article.
-
Sector retinitis pigmentosa.Optometry. 2005 May;76(5):309-17. doi: 10.1016/s1529-1839(05)70314-6. Optometry. 2005. PMID: 15884421
Cited by
-
Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care.Cells. 2024 Jan 17;13(2):179. doi: 10.3390/cells13020179. Cells. 2024. PMID: 38247870 Free PMC article. Review.
-
Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa.Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5417-5430. doi: 10.1167/iovs.18-25345. Invest Ophthalmol Vis Sci. 2018. PMID: 30452595 Free PMC article.
-
Cell Ferroptosis: New Mechanism and New Hope for Retinitis Pigmentosa.Cells. 2021 Aug 21;10(8):2153. doi: 10.3390/cells10082153. Cells. 2021. PMID: 34440922 Free PMC article. Review.
-
Mesenchymal stem cell surgery, rescue and regeneration in retinitis pigmentosa: clinical and rehabilitative prognostic aspects.Restor Neurol Neurosci. 2020;38(3):223-237. doi: 10.3233/RNN-190970. Restor Neurol Neurosci. 2020. PMID: 32310198 Free PMC article.
-
Pluripotent Stem Cells for the Treatment of Retinal Degeneration: Current Strategies and Future Directions.Front Cell Dev Biol. 2020 Aug 14;8:743. doi: 10.3389/fcell.2020.00743. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32923439 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources